Background: Cases of endometriosis with no tubal damage are associated with infertility, suggesting an immunological rather than mechanical barrier to reproduction. Laparoscopy and falloposcopy results of clinically asymptomatic women undergoing investigation of infertility were correlated with the outcomes of microbiological screening for Chlamydia trachomatis, Mycoplasma pneumoniae, Mycoplasma hominis, ureaplasma species, Neisseria gonorrhoeae, Neisseria meningitidis and Chlamydia pneumoniae. Methods: A total of 44 women presenting to a hospital IVF service for laparoscopic or laparoscopic/ falloposcopic investigation of infertility provided endocervical swabs, fallopian tube washings, and peripheral whole blood for analysis. Results: Of these 44 women, 15.9% (7) showed evidence of C. trachomatis infection as detected by either PCR or EIA serology. Of these 7 women, 5 (71%) had no or mild endometriosis and 2 (29%) had moderate or severe endometriosis. Of the remaining 37 women who showed no evidence of chlamydial infection, 15 (40.5%) had no or mild endometriosis. Conclusion: Women with infertility, but without severe endometriosis at laparoscopy, showed a trend towards tubal damage and a higher rate of previous C. trachomatis infection. Although not statistically significant, this trend would suggest that, where moderate to severe tubal damage is found to be the primary cause of infertility, C. trachomatis infection could be a likely cause for such tubal damage.
INTRODUCTION
Intraluminal pathology of the fallopian tube is correlated with two conditions-pelvic inflammatory disease (PID) and endometriosis. The presence of such tubal disease is a strong determinant of infertility 1 ; 20 to 25% of infertile women have been shown to have endometriosis compared with 2 to 5% of fertile women 2 , and up to a third of women with endometriosis show evidence of salpingitis 3 . Whereas severe cases of endometriosis accompanied by extensive pelvic adhesions can lead to tubal infertility, mild or moderate cases with no tubal damage are also associated with infertility, suggesting an immunological rather than a mechanical barrier to reproduction 4, 2 . PID also causes tubal infertility. The severity of tubal damage occurring during PID determines the probability of infertility: 3% of women with mild tubal damage observed at laparoscopy, 13% with moderate damage, and 29% with severe damage, were identified as having tubal infertility 5 . Despite the high causal relationship between bacterial infection and PID, organisms are rarely isolated in PID cases, and even less frequently in cases of tubal infertility 6 . Most women with tubal infertility do not have a history of recognised acute salpingitis. However, a number of previous studies investigating acute infections, pelvic inflammatory disease and salpingitis have demonstrated that Chlamydia trachomatis and Neisseria gonorrhoeae are the most common causes of such infection [7] [8] [9] [10] ; and others have demonstrated an abnormally high prevalence of antichlamydial (C. trachomatis) antibodies in women with tubal infertility and ectopic pregnancy [11] [12] [13] [14] [15] . In this study we investigated the severity of intraluminal disease, endometriosis and evidence for microorganisms associated with PID among a cohort of clinically asymptomatic women undergoing laparoscopy or laparoscopy/falloposcopy for the investigation of infertility. The objective was to determine the prevalence of, and possible relationship between, asymptomatic infection and pathology of the fallopian tubes consequent to endometriosis and PID. This study reports on pathological findings at laparoscopy or laparoscopy/ falloposcopy, and outcomes of micro-biological screening for microorganisms including C. trachomatis, M. pneumoniae, M. hominis, ureaplasma species, N. gonorrhoeae and N. meningitidis, and serological testing for C. trachomatis, C. pneumoniae and M. pneumoniae.
MATERIALS AND METHODS

Participants
This study involved 44 women presenting to a hospital IVF service for laparoscopic and falloposcopic investigation of infertility. These women had a history of infertility of at least 2 years' duration, were clinically asymptomatic for PID, and either had a history of signs and symptoms suggestive of endometriosis, or a previous diagnosis of tubal disease as confirmed by previous laparoscopy, or longstanding unexplained infertility. All subjects had had other forms of infertility investigated (male factor, ovulation defects) before undergoing laparoscopy or laparoscopy/ falloposcopy. Informed consent was obtained from all participants and the study was approved by the human ethics committees of the Queensland University of Technology and the Wesley Hospital, Brisbane, Queensland.
Clinical samples
Three separate clinical samples were collected from each of the participants: endocervical swabs for culture and PCR analysis; fallopian tube washings for culture, PCR analysis and serology; and 10 ml peripheral whole blood for serological assay. The endocervical swabs were collected during a speculum examination before the laparoscopy/falloposcopy procedure. The cervix was then prepared for falloposcopy and swabbed with povidone iodine. As a matter of protocol, all women were treated with antibiotics before the insertion of instrumentation through the cervix, in order to reduce the possibility of pelvic infection due to contamination carried from the vagina. Cefotaxamine sodium, 2 g intravenously, was administered at the commencement of the procedure.
During falloposcopy an endoscope (Imagyn Medical, Switzerland) was inserted through the cervix and uterus into the fallopian tubes. The tubes were visualised along their length by means of a linear everting catheter and falloposcope. Saline was passed through the fallopian tube and any tissue debris or adhesions within the tubal lumen were cleared if possible during this procedure. The resultant cellular debris and saline were collected from the pouch of Douglas by aseptic aspiration via laparoscopy and aliquotted for testing. In 5 cases severe tubal pathology precluded falloposcopic examination, although saline was forced through under pressure. Thus fallopian tube washings were collected in these 5 cases although falloposcopic observation was not possible.
Classification of endometriosis
The classification of endometriosis employed in this study was a modification of the American system, developed specifically with reference to fertility outcomes. Laparoscopic observations of endometriosis were classified according to the extent and distribution of endometriosis and the presence of adhesions. The presence of some peritoneal endometriosis deposits, with no endometriosis on tubes or ovaries and no pelvic adhesions, was classed as mild. The presence of peritoneal endometriosis deposits and/or pelvic adhesions, with superficial endometriosis deposits on the ovarian capsule but no periovarian or peritubal adhesions, was classed as moderate. Endometrioma formation in the ovaries, extensive peritoneal endometriosis, extensive pelvic adhesions, and deposits of endometriosis on tubal serosa with or without peritubal/periovarian adhesions constituted severe endometriosis.
Classification of intraluminal disease
Falloposcopy findings observed inside the fallopian tubes were classified as follows. Minimal loss of intraluminal folds with no adhesions or obstruction in either fallopian tube was classed as mild. Complete obstruction of one or incomplete obstruction of either one or both tubes, with moderate adhesions and moderate loss of tubal mucosal folds, was classed as moderate. Intraluminal tubal pathology (found at falloposcopy to be the primary cause of infertility) with permanent bilateral obstruction or extensive loss of normal intraluminal tubal architecture (presence of intratubal adhesions and loss of tubal mucosal folds) constituted severe disease.
Detection of C. trachomatis and neisseria
species.
Endocervical swabs were tested by Amplicor CT/NG PCR (Roche Diagnostics, Branchburg, NJ, USA) for both C. trachomatis and N.
gonorrhoeae (according to the manufacturer's instructions), and cultured for N. meningitidis using chocolate agar incubated overnight at 358C. Samples of fallopian tube washings obtained from falloposcopy and/or laparoscopy were also tested for C. trachomatis by the Roche Amplicor CT/NG PCR and cultured for both N. gonorrhoeae and N. meningitidis using Thayer Martin/chocolate agar. The Roche Amplicor CT/NG PCR method incorporates an internal control to monitor for the presence of PCR inhibitors.
Antibody screening
Peripheral blood serum and fallopian tube washings collected from participants were tested for anti-C. trachomatis IgG and IgA antibodies and anti-C. pneumoniae IgG antibodies. C. trachomatis antibodies were detected using the Labsystems Chlamydia trachomatis IgG EIA and IgA EIA (Helsinki, Finland). C. pneumoniae IgG antibodies were detected by immunofluorescence using the FOCUS Chlamydia MIF (Los Angeles, USA). An agglutination assay (Fujirebio Serodia-MYCOII, Japan) was selected for determination of M. pneumoniae antibodies using washings only. Serum samples were tested and interpreted for C. trachomatis and C. pneumoniae antibodies according to the manufacturer's instructions. As no criteria were supplied for samples other than blood, the following adaptations were made for testing the fallopian fluids. Samples of C. trachomatis were initially tested undiluted; if positive, they were retested at dilutions of 1:2 and 1:10 prepared using sample diluent. C. pneumoniae samples were initially tested at 1:16 dilution; and M. pneumoniae samples were initially tested at 1:4 dilution.
Ureaplasma/ mycoplasma detection Ureaplasma culture
Endocervical swabs (39 samples tested) and fallopian tube washings (40 samples tested) were inoculated directly into 10B broth 16 and then held at -808C until testing. In the laboratory, four serial 10-fold dilutions were made of the liquid broth, which was then incubated at 378C until ureaplasma growth was detected by an alkaline shift or for 3 weeks.
Ureaplasma/mycoplasma PCR detection
All clinical samples were prepared for extraction of DNA by the method of Blanchard et al 17 . All endocervical and fallopian tube clinical samples were tested by PCR assay for the presence of ureaplasmas. M. hominis and all endocervical ureaplasma isolates identified as U. parvum were further subtyped using four separate single-step mba PCR assays by previously described methods 18 . For M. pneumoniae testing, primers specific for the species were designed using the P1 and ORF453 genes of M. pneumoniae and an annealing temperature of 528C. Primers were designed to avoid regions of high homology with Mycoplasma genitalium and Ureaplasma urealyticum sequences. ORF 453 encodes a possible protoporphyrinogen oxidase, and primers ORF-F (5' TCAACTACCCT-TACCCTATTACC 3') and ORF-R (5' GCACTCCAGTATCACTTGTT-TAAC 3') generate an amplicon of 505 bp. Primers to the P1 major adhesin of M. pneumoniae were designed in the constant region 1 to avoid repetitive elements 19 and variable regions 20 . PCR amplification using primers P1-F (5' CTTACTGT-TCTCAGGCATGG 3') and P1-R (5' TTGACAAGACCGTCCA-ATCC 3') produced a fragment of 383 bp. M. pneumoniae DNA kindly supplied by G. Browning, University of Melbourne, was used as a control. The PCR reaction mixture and thermal cycling conditions were those previously described 18 .
Other bacteriological culture
An endocervical swab was also cultured on horse blood and Sabouraud's dextrose agar and incubated overnight at 358C.
Statistical analysis
Associations of chlamydia infection between women with nil/mild and moderate/severe endometriosis and tubal disease were examined by two-way tables using chi-squared and Fisher's exact tests.
RESULTS
Laparoscopy and falloposcopy results
Of the 44 women enlisted in this study, 5 underwent a laparoscopy procedure but did not proceed to falloposcopy; however, in these cases fallopian tube washings were obtained as a result of saline being washed through. Endocervical cultures for the remaining women grew the bacterial flora that could normally be expected after vaginal contamination.
Fallopian tube culture/PCR results C. trachomatis was detected in the fallopian tubes of 1 woman (Table 1) . Serology for both fallopian washings and serum for this woman was found to be negative for C. trachomatis, and no other fallopian tube sample was found to be positive for C. trachomatis. Ureaplasmas, M. hominis, M. pneumoniae, N. gonorrhoeae and N. meningitidis were not detected in any of the fallopian tube samples.
Antibody testing
Both serum and fallopian tube fluids were available for serological testing for 38 of the 44 women; for 3 women only serum was tested and for 3 only fallopian tube fluid was tested.
Peripheral blood serology
Of the 41 serum samples, 4 (9.8%) were positive for C. trachomatis IgG, and 1 (2.4%) for C. trachomatis IgA ( but only 2 (28.6%) of these 7 women had moderate to severe endometriosis. In 1 case with positive mycoplasma serology (fallopian tube fluid), mild endometriosis was defined, with severe tubal disease and a history of ruptured appendicitis.
Of the remaining 37 women who showed no microbiological evidence of chlamydial infection, 11 (29.7%) had a diagnosis of mild endometriosis, 13 (35.1%) of moderate endometriosis, and 9 (24.3%) of severe endometriosis, whereas 4 (10.8%) had no endometriosis. According to falloposcopic observations, 5 (13.5%) of women in this same group had no or mild tubal disease and 32 (86.5%) had moderate to severe tubal disease.
The laparoscopy and falloposcopy results for those women with C. trachomatis positivity, and those with none, were grouped into two general categories of endometriosis and tubal disease (nil/ mild and moderate/severe) and are described in Table 2 .
Among the women with evidence of chlamydial infection, 71% had a diagnosis of nil/mild endometriosis diagnosis compared with 40.5% of women with no evidence of chlamydia (p 4 0.5). Among the women with evidence of chlamydia and classifications of nil/mild endometriosis, 56.7% showed moderate/severe tubal damage compared with 32.4% of women without positive chlamydia serology and with nil/mild endometriosis (p 4 0.5).
The 9 women with endocervical ureaplasma infection were evenly distributed across both groups of endometriosis: 44% had nil/mild endometriosis and 56% had moderate/severe endometriosis.
A review of the clinical histories of the participants showed that of the 7 women with evidence of C. trachomatis infection, 1 gave a history of miscarriage, 1 gave a history of ectopic pregnancy, and 2 had had PID previously. Another 2 participants in this group displayed significant tubal disease indicative of previous infection. In comparison, the clinical histories of the other 37 women included (in addition to endometriosis) 5 cases of polycystic ovarian disease, 4 of irregularities with ovulation, 1 of possible PID at a very early age (no tubal disease was detected), 1 of hydrosalpinx, 1 of suspected infection from a previous termination of pregnancy and 2 of appendicitis.
When serum samples were assayed for C. pneumoniae, equivalent proportions of patients with either nil/mild or moderate/severe endometriosis were found to have positive serology for C. pneumoniae (44% and 56%, respectively).
DISCUSSION
C. trachomatis is now recognised as one of the most common sexually transmissible bacterial pathogens throughout the world. C. trachomatis has previously been found to be the primary cause of salpingitis and pelvic inflammatory disease (30 to 60% of cases) [7] [8] [9] [10] 21 , often with consequent ectopic pregnancy 22 and tubal infertility 23, 24 . The presence of C. trachomatis DNA at sites of inflammation and tissue damage within reproductive tissue in both animal models 25 and humans with PID and tubal infertility [26] [27] [28] [29] suggests that chlamydia persist within the fallopian tube in a non-replicative chronic state and may be directly involved in the stimulation of the immune-mediated tissue destruction.
However, despite strong evidence of C. trachomatis involvement in tubal infertility, isolation of the organism by culture is rare 28 . Falloposcopy as performed for this cohort of women remains one of the few options for obtaining fallopian tissue for analyses. However, in our study tissue biopsies were not taken. In view of the intracellular reproductive cycle of C. trachomatis, the collection of luminal tissue for testing is ideal, but the process of clearing out debris by means of the passage of saline through the fallopian tube was considered sufficient in our study to provide suitable material for PCR testing. Nonetheless, one deficiency in this approach was our failure to collect pre-existing cul-de-sac fluid before aspiration of the tubal effluent. This study reports the microbiological screening of cervical, serum and fallopian tube samples collected from women undergoing laporoscopic and/or falloposcopic investigation for infertility. A total of 7 women (15.9%) within our cohort of 44 women showed evidence of previous C. trachomatis infection, either in the form of serum IgG (n = 4) and/or IgA antibodies (n = 1), fallopian tube IgG (n = 5) and/or IgA (n = 1) antibodies, or chlamydial DNA detected by PCR in the fallopian tube washings (n = 1). This prevalence, recorded in a population of women accessing an infertility service, is as expected higher than both the general and antenatal prevalence rates. The prevalence of 3 to 5% in the general community was calculated from urine-based PCR among, for example, adult clients attending the Brisbane Sexual Health Clinic on any given month (unpublished data). The antenatal prevalence of 3.7% was previously reported in antenatal patients attending a public hospital clinic 30 . The prevalence (15.9%) found in this study is comparable with that reported by other studies. In a previous study of 1303 subfertile couples, asymptomatic for genital tract infection, elevated titres of IgG anti-chlamydial antibodies were found in 20.8% of all women 11 . Similarly Vogelzang et al. 31 , in a study of infertile women referred to an IVF provider for diagnostic laparoscopy, found that 7/33 (21.2%) women with tubal disorders (adhesions, distal occlusions and strictures) demonstrated antibodies to C. trachomatis compared with 0/20 of women without tubal damage. Further studies have also strongly supported the link between serological evidence of previous C. trachomatis infections and tubal infertility and ectopic pregnancies [12] [13] [14] [15] . The detection of antibodies to C trachomatis within fallopian tube washings collected does not necessarily reflect actual antibody production in the tubes but could also be the result of serum transudate or contamination by blood washed through with the dislodged cellular debris and fragments of endometrium.
In this current study we also compared the prevalence and severity of endometriosis in women positive and negative for C. trachomatis. Although there was no statistical significance, there appeared to be a trend in which a higher proportion of those infertility clinic clients returning a positive C. trachomatis diagnosis recorded nil/mild categories of endometriosis (5/7: 71%) compared with those women without any evidence for C. trachomatis (15/37: 40.5%). Also, there was a trend in which a lower proportion of positive C. trachomatis diagnoses recorded moderate/severe categories of endometriosis (2/7: 29%) compared with the negative group (22/37: 59.5%). Again this was not significant in view of the small numbers. These results suggest a negative relationship between C. trachomatis and endometriosis. Therefore, in this current study, endometriosis appears not to be associated with a previous history of C. trachomatis infection. A previous study had similarly found that only 1/15 patients with endometriosis had detectable antibodies to C. trachomatis 14 . The majority of participants in this present study were found during falloposcopy to have moderate/severe intraluminal disease (38/44: 86.4%). Moderate/severe tubal damage was observed in women with both nil/mild and moderate/severe endometriosis (87.1% and 80.4%, respectively). Therefore the severity of the tubal damage did not relate to the endometriosis classification. 16/44 (36%) of the women in our study presented with moderate to severe tubal damage in the absence of moderate to severe endometriosis. Although 25% (4/16) of these women showed evidence of C. trachomatis infection, the aetiology of tubal damage for the remaining 12 women remained undefined.
When both endometriosis and tubal disease were investigated together, 56.7% of participants with positive C. trachomatis findings had moderate/severe tubal disease and nil/mild endometriosis, whereas only 32.4% of participants without evidence of C. trachomatis infection had similar categories of intraluminal disease and endometriosis. Therefore the findings of tubal damage in those women with evidence of C. trachomatis may be due to this previous infection, in view of the fact that endometriosis was predominantly mild or non-existent for this group.
A more speculative explanation for the higher prevalence of C. trachomatis among this small sample of women with nil/mild endometriosis may be a protective effect. Could C. trachomatis infection limit the extent and severity of endometriosis or, conversely, does a pre-existing endometriosis condition limit C. trachomatis infection? It may be possible that tubal occlusion resulting from C. trachomatis infection may create a physical barrier against endometrial tissue passing through the fallopian tube or, alternatively, immune responses generated during endometriosis such as elevated cytokine expression 2, 32, 33 , increased neutrophil activity [34] [35] [36] and increased phagocytic activity 37, 38 may clear chlamydial colonisation before the development of florid infection.
The prevalence of C. pneumoniae antibodies in sera was evenly distributed across both classifications of endometriosis (Table 3) , and there did not appear to be an association with C. trachomatis serology. Freidank et al. 39 showed a higher anti-hsp60 antibody rate in patients with complete tubal occlusion (76%) than in infertility patients with normal fallopian tubes (19%), and this was associated with the presence of antibodies not only to C. trachomatis but also to C. pneumoniae, suggesting a synergistic effect due to cross-reactivity. However, Osser and Persson 40 had earlier argued against the possibility of cross-reactivity due to shared antigens by demonstrating that antibodies to C. pneumoniae did not influence the frequency or titre of antibodies to C. trachomatis in patients recovering from acute salpingitis. C. trachomatis antibodies, however, did reflect the severity of inflammatory involvement. More recently 41 , patients with tubal factor infertility were shown to have significantly higher frequencies and titres for all antibodies (C. trachomatis hsp60, hsp10, common chlamydial lipopolysaccharide) except to C. pneumoniae. No interaction between C. trachomatis and C. pneumoniae suggestive of a synergistic effect was found. The results of our study would suggest a similar trend, although the numbers of patients were too small for statistical significance.
In this study we also tested endocervical swabs and fallopian tube washings for the presence of the ureaplasmas (U. parvum, U. urealyticum), M. hominis and M. pneumoniae. Whereas M. hominis and M. pneumoniae were not detected in either endocervical or fallopian tube samples, 28% of the women tested were found to have U. parvum in the endocervix. However, no ureaplasmas were detected in the fallopian tube washings by either culture or PCR. Testing of the fallopian tube specimens using a more sensitive nested mba PCR assay (results not shown) also failed to detect ureaplasmas within these specimens. These results confirm that the fallopian tube specimens had not been contaminated during the transcervical falloposcopy procedure.
Previous studies demonstrated a very low isolation rate of the ureaplasmas (0 to 3%) and M. hominis (0 to 4%) from the fallopian tubes 7, 9 . This is despite higher ureaplasma/M. hominis colonisation rates in the endocervix (48 to 52%) and the endometrium (6 to 30%). However, these studies highlighted the increased prevalence of C. trachomatis: 30% of women were infected with C. trachomatis in the endometrium and 17 to 22% of women demonstrated infection within fallopian tubes 7, 9 . M. pneumoniae was not detected in either endocervical or fallopian tube samples in this current study, but this microorganism has been associated with orogenital contact and has been isolated from cervical and male urethral swabs 42 . A rare case of tubo-ovarian abscess has also been reported after pneumonia, indicating the possibility of systemic spread 43 . Our study also shows that there is no association between the prevalence of endometriosis and U. parvum, given that 44.4% of women with endocervical ureaplasmas had nil/mild endometriosis compared with 55.6% of ureaplasmapositive women with moderate/severe endometriosis.
N. meningitidis, another respiratory pathogen and coloniser, has also been isolated from the female genitourinary tract in both symptomatic and asymptomatic states, and is generally associated with orogenital contact 43 . Symptomatic infections range from urethritis to purulent cervicitis and salpingitis. In our population sample of 44 women, no N. meningitidis was isolated from either cervix or fallopian tube by culture. Whereas the prevalence of anogenital infection in the UK has remained very low at 0.13%, other studies in the USA have isolated N. meningitidis in 20% of cases urogenital detection of pathogenic Neisseria species 43 . Other organisms identified in the endocervix of these women were considered consistent with lower genital tract flora, as no participants in the study had symptoms of PID or vaginitis.
The evidence for C. trachomatis infection identified in 15.9% of women involved in this study was comparable with previous studies and was certainly higher than the prevalence (3.7%) within a population of fertile Australian women 30 . The absence of C. trachomatis indicators in women with moderate to severe endometriosis, and the comparable rates of women with and without evidence for ureaplasma across all groupings of endometriosis, supports a non-microbial cause for endometriosis. Further, this study may suggest a protective effect by which previous chlamydial-induced tubal damage may limit the spread of endometriosis, or immune responses associated with endometriosis may prevent chlamydia infection. Our study also suggested that there was no synergistic link between C. pneumoniae and C. trachomatis infection with respect to inducing tubal damage. Finally, a third of the women in our group who presented with moderate to severe intraluminal disease had no significant evidence of endometriosis. Whereas 25% of this group showed some evidence for previous C. trachomatis infection, there remained a majority with no apparent microbiological cause for their tubal disease.
